verified SJR 1,589 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · Elsevier Ltd

workspace_premium Q1 — Pharmacology lock Subscription

Neuropharmacology

Neuropharmacology is a journal indexed in SJR in Pharmacology and Cellular and Molecular Neuroscience with an H index of 199. It has an SJR impact factor of 1,589 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,589.

Neuropharmacology focuses its scope in these topics and keywords: receptor, rat, nucleus, cholinergic, vitro, receptors, effects, alzheimers, activation, dorsal, ...

ISSN: 0028-3908

Publisher: Elsevier Ltd

Category: Pharmacology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,589 Q1

H-index 199

Acceptance rate pie_chart

20% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,589

H-index

199

Docs (year)

247

Docs 3y

834

Total refs

20932

Cites 3y

4346

Citable 3y

816

Cites/Doc 2y

4.9

Ref/Doc

84.74

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Benzodiazepine Site Pharmacokinetic/Pharmacodynamic Quantification in Man: Direct Measurement of Drug Occupancy and Effects on the Human Brain In Vivo

Wild-type and Insecticide-resistant Homo-oligomeric GABA Receptors of Drosophila melanogaster Stably Expressed in a Drosophila Cell Line

Discriminative stimulus properties of the putative dopamine D3 receptor agonist, (+)-PD 128907: role of presynaptic dopamine D2 autoreceptors

Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO60-0175: a pharmacological analysis

Design and models for estimating antagonist potency (pA2, Kd and IC50) following the detection of antagonism observed in the presence of intrinsic activity

Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)2 receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT2A receptor mediation of the HPA axis

Clozapine is a partial agonist at cloned, human serotonin 5-HT1A receptors

Chronic treatment with antidepressants affects glycine/NMDA receptor function: behavioral evidence

Chronic clomipramine alters presynaptic 5-HT1B and postsynaptic 5-HT1A receptor sensitivity in rat hypothalamus and hippocampus, respectively

Cannabinoid inhibition of guinea-pig intestinal peristalsis via inhibition of excitatory and activation of inhibitory neural pathways

Calcium-dependent release specificities of various cell lines loaded with different transmitters

Bradycardic responses to microinjection of N-methyl-d-aspartate into the nucleus tractus solitarius are inhibited by local activation of 5-HT3 receptors

SHOW MORE ARTICLES

Block of spatial learning by mG1uR agonist tADA in rats

8-OH-DPAT-induced Spontaneous Tail-flicks in the Rat are Facilitated by the Selective Serotonin (5-HT) 2C Agonist, RO 60-0175: Blockade of its Actions by the Novel 5-HT 2C Receptor Antagonist SB 206,553

Apparent Independent Action of Nimodipine and Glutamate Antagonists to Protect Cultured Neurons Against Glutamate-induced Damage

Antidepressants: New pharmacological strategies

Anticonvulsant activity of 3,4-dicarboxyphenylglycines in DBA/2 mice

Amphetamine releases GABA in striatum of the freely moving rat: involvement of calcium and high affinity transporter mechanisms

Alpha-methylated tryptamine derivatives induce a 5-HT receptor-mediated head-twitch response in mice

Activation of Phospholipases C and D by the Novel Metabotropic Glutamate Receptor Agonist tADA

Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT2C/2B receptor antagonists: neurochemical and behavioural studies

ACPD-mediated slow-onset potentiation is associated with cell death in the rat CA1 region in vivo

A Functional Comparison of the Antagonists Bicuculline and Picrotoxin at Recombinant GABA A Receptors

A comparison of multiple injections versus continuous infusion of nicotine for producing up-regulation of neuronal [3H]-epibatidine binding sites

FAQs

Neuropharmacology has an SJR of 1,589 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Neuropharmacology is 20%.

Neuropharmacology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Neuropharmacology?

What is the APC / publication cost?

What is the acceptance rate?